UBS Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-8,513
| Closed | -$4K | – | 7488 |
|
|
2018
Q4 | $4K | Buy |
+8,513
| New | +$4K | ﹤0.01% | 6758 |
|
|
2018
Q2 | – | Sell |
-6,516
| Closed | -$16K | – | 7472 |
|
|
2018
Q1 | $16K | Buy |
6,516
+4,878
| +298% | +$12K | ﹤0.01% | 5718 |
|
|
2017
Q4 | $4K | Sell |
1,638
-999
| -38% | -$2.44K | ﹤0.01% | 6530 |
|
|
2017
Q3 | $8K | Buy |
2,637
+1,496
| +131% | +$4.54K | ﹤0.01% | 6127 |
|
|
2017
Q2 | $5K | Buy |
1,141
+359
| +46% | +$1.57K | ﹤0.01% | 6227 |
|
|
2017
Q1 | $3K | Sell |
782
-2,184
| -74% | -$8.38K | ﹤0.01% | 6321 |
|
|
2016
Q4 | $6K | Buy |
2,966
+192
| +7% | +$388 | ﹤0.01% | 6223 |
|
|
2016
Q3 | $17K | Sell |
2,774
-2,945
| -51% | -$18K | ﹤0.01% | 5552 |
|
|
2016
Q2 | $25K | Buy |
5,719
+5,201
| +1,004% | +$22.7K | ﹤0.01% | 5263 |
|
|
2016
Q1 | $5K | Sell |
518
-2,475
| -83% | -$23.9K | ﹤0.01% | 6180 |
|
|
2015
Q4 | $88K | Sell |
2,993
-3,497
| -54% | -$103K | ﹤0.01% | 4323 |
|
|
2015
Q3 | $205K | Buy |
6,490
+2,700
| +71% | +$85.3K | ﹤0.01% | 3699 |
|
|
2015
Q2 | $224K | Sell |
3,790
-320
| -8% | -$18.9K | ﹤0.01% | 3794 |
|
|
2015
Q1 | $439K | Buy |
4,110
+810
| +25% | +$86.5K | ﹤0.01% | 3307 |
|
|
2014
Q4 | $310K | Buy |
+3,300
| New | +$310K | ﹤0.01% | 3496 |
|